Progression-free survival (PFS) by risk factors. PFS by overall treatment arm by MIPI (A-C). In patients with tissue available to study: by Ki-67 at 30% cut-off (D) and by TP53 immunohistochemistry at 50% cutoff (E).
Figure 3.

Progression-free survival (PFS) by risk factors. PFS by overall treatment arm by MIPI (A-C). In patients with tissue available to study: by Ki-67 at 30% cut-off (D) and by TP53 immunohistochemistry at 50% cutoff (E).

This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal